APOLLO HOSPITALS INVESTMENT
Block deals worth over Rs 9,947 crore this week. HDFC Bank, Infosys, Adani Ports among stocks with major action
In the large cap segment, 15 companies witnessed significant block deals worth Rs 5,725 crore led by HDFC Bank with 43 block counts totalling to Rs 2,446 crore. The next in line were Adani Ports and Special Economic Zone (Rs 469 crore), Godrej Consumer (Rs 421 crore), TVS Motor Company (358 crore), Infosys (Rs 339 crore), Interglobe Aviation (Indigo, Rs 288 crore) and Maruti Suzuki (Rs 218 crore).
Hot Stocks: Brokerage view on Stylam, Apollo Hospitals, ICICI Bank and Adani Wilmar
Investec's diversified coverage includes insights on Adani Wilmar, ICICI Bank, Apollo Hospitals, Stylam Industries, and Ratnaveer Precision Engineering, providing a comprehensive view of the market opportunities and risks.
Google Cloud’s AI push is winning clients: Thomas Kurian
Google Cloud chief sees tech infra that govt wants to put together as an opportunity to work closely with India. He says so many Indian entrepreneurs are aspiring to build the next Google... ‘we are super supportive of it’.
Hot Stocks: Brokerage view on Havells India, Apollo Hospitals, Zomato and TBO Tek
Top brokerage firms like Jefferies, Kotak Securities, and Goldman Sachs have issued ratings and targets for Havells India, Apollo Hospitals, and TBO Tek.
Hot Stocks: Brokerage view on Apollo Hospitals, Senco Gold, Crompton Greaves & Havells India
Motilal Oswal initiated coverage on Senco Gold, Kalyan Jewellers, Apollo Hospitals, Crompton Greaves Consumer, and Havells India with buy ratings and revised target prices. UBS and Goldman Sachs also provided insights on the healthcare and consumer durables sectors, respectively, highlighting growth prospects and market trends.
These healthcare and pharma stocks may deliver more than 20% in one year
Check out Stock Reports Plus, powered by Refinitiv, for price targets of over 4,000 listed stocks along with detailed company analysis focusing on five key components - earnings, fundamentals, relative valuation, risk and price momentum to generate standardized scores. SR+ Reports is a complimentary offering to ETPrime members.
- Go To Page 1
Canon in talks with Indian, global players to supply chip making machine
Canon is exploring partnerships with Indian and global players for semiconductor lithography equipment essential in chip fabrication, aiming to challenge ASML. The company is in talks with semiconductor firms investing in India, including Tata Group and PSMC. Canon also launched Canon Medical Systems India to meet the rising demand for medical equipment, targeting key markets like Chennai, Hyderabad, and Mumbai.
ET Analysis: Indian hospital chains report revenue growth & expansion plans amidst regulatory concerns
Leading hospital chains in India have reported improved average revenue per operating bed (ARPOB) and profitability in the latest quarter, driven by better payer mix and cost control measures. Expansion plans are underway, with a focus on markets like Bengaluru and Mumbai, through asset-light models. Adjacent businesses such as diagnostics, virtual care, and digital healthcare platforms are also seeing growth. However, regulatory proposals to rationalize rates may pose risks to sector valuations.
Hot Stocks: Brokerages view on Aurobindo Pharma, Apollo Hospitals, Suzlon & Titan Company
Top brokerage firms like Macquarie maintained an outperform rating on Aurobindo Pharma, raising the target price to Rs 1,385. Aurobindo Pharma signed a master service agreement with Merck Sharp & Dohme, leading to a biologics CMO contract with TheraNym.
Planning to invest Rs 3,000 crores to add 2,000 beds in 3 years: Suneeta Reddy, Apollo Hospitals
Let us look at both ARPOB, it is over 59,000, it is about Rs 59,0330. We have seen an increase in ARPOB of around 12%, but more importantly just going forward, this is because of a better case mix and price, but definitely improved case mix. With regard to volumes, inpatient volumes grew by 6%, outpatient volumes grew by 9%. And our ARPOB is net of doctors’ fees.
Hot Stocks: Brokerage view on HDFC Bank, Apollo Hospitals & Zomato; BofA upgraded M&M
Brokerage firm Macquarie maintained an underperform rating on Zomato and Apollo Hospitals. BofA Securities recommended a buy on HDFC Bank and upgraded M&M to a buy.
Q4 results today: Apollo Hospitals among 895 companies to announce earnings on Thursday
Fourth quarter earnings season is wrapping up with 895 companies reporting results on Thursday. Investors keenly await Apollo Hospitals' results, expecting robust growth driven by improved ARPOB and HealthCo operations. Analysts predict up to a 68% YoY increase in net profit, with sales expected to rise by 13%.
Stocks in news: Apollo Hospitals, Muthoot Finance, Tata Steel, Kfin Tech, RR Kabel
Tata Steel Ltd on Wednesday reported 64% fall in its consolidated net profit at Rs 611 crore for the fourth quarter, compared with Rs 1,705 crore in the same quarter a year earlier.
Stocks to buy: Bet on stocks with good entry points now; 5 stocks with up to 27% upside potential
Stocks to buy: Identifying recently corrected stocks with good fundamentals can be effective in the current market. Moving averages help distinguish between stocks in correction and those in a bear trend. Stocks that have seen a recent correction and are fundamentally sound can prove good investment bets.
Defensive stocks: FMCG is “passe”; 8 stocks from two sectors may be called “new defensives” with upside potential of up to 32%
1994 to 2024 is a difference of 30 years, but there is one thing which has remained constant, advice to move to defensive stocks when markets are volatile or there is an event risk. Four questions need to be asked; first, what is a defensive stock? Second, is a stock which was considered a defensive in 1994 when the Indian economy was just opening, still a defensive stock in 2024 ? Third, should there be a new definition of defensive stock in 2024 ? Last but not the least, what are the new defensive sectors or stocks?
Hospital chain Artemis Medicare raises Rs 330 crore from IFC
Artemis Medicare Services has raised Rs 330 crore from IFC to increase bed capacity and introduce advanced specialty services. The company plans to set up cardiac care centers, expand in tier 2 and 3 cities, and in the Delhi NCR region through brownfield and greenfield opportunities. Artemis operates 713 beds in the Delhi NCR region and runs seven centres under the Artemis Cardiac Care brand in a joint venture with Philips.
Ambulances startup Red.Health raises $20 million led by Jungle Ventures
Hyderabad-based startup Red.Health will use the fresh capital to innovate its product, advance its technology, and improve its dispatch system to minimise human errors and optimise response time.
PE fund Apax to step up India play with new team
The Apax strategy is more pivoted toward control deals, given its focus on being able to have a seat on the table to drive changes. It is, however, open to partnering with quality founders and management teams in minority settings "where there's a meeting of minds," Haldea said.
Sensex can zoom to 1.5 lakh by 2029 but don't be a speculator
While there are several reasons for this surge, peaks and troughs, booms and busts are an integral part of the stock market saga - much like the waves of the sea, which incessantly rise and fall. Hence, there could be an element of “irrational exuberance”, “froth” and “bubble”.
Will short-term headwinds impact long-term potential? 6 stocks from hospital sector with upside potential of up to 30%
After outperforming the market, stocks from the healthcare sector or what is more commonly called hospital sector have gone into consolidation mode. The consolidation has been prompted by the fact that voices have been raised about differential pricing in the services of the hospitals. The matter has reached the Supreme Court and will be heard. Given the fact that while medicine is a science but in real life as practice it has an element of art in it. For example, a hospital who has a renowned surgeon from any branch, be it cardio, neuro on its roll may charge up more for the same surgery as compared to others. While the moral debate is on one side, there is another side to the story. In a country like India, the healthcare infrastructure needs vast expansion and upgradation. To some extent the street is ruthless and does not have much moral obligation.
Valuation of Apollo HealthCo will go up by many multiples due to integration of Keimed: Suneeta Reddy, Apollo Hospitals
The most important segment, of course, is the offline pharmacy currently and that segment if you look at the growth, it is happening at 20%. Online is growing much faster at over 70%, so this has been reflected in the growth in GMV.
Apollo Hospitals share price falls 8% post stake sale and Keimed merger
The brokerage has reduced its pharmacy target valuation from 25x to 22x, resulting in a lower SoTP by Rs 290 per share. "Keeping the hospital multiple intact (24x) and rolling over to FY26, our revised target price is Rs 7,300 (from Rs 7,500); we maintain ‘BUY’," it said.
Downside limited to 5-10% for larger IT companies, but not much upside also: Sandip Sabharwal
Sandip Sabharwal expresses concerns about the IT sector due to unclear growth trends and excessively bullish management on margins. In auto stocks, Maruti's resurgence cycle looks promising, while ICICI Bank stands out among private banking majors. Skipping the IT sector is advised, with cautious optimism towards Apollo Hospitals and turnaround banks.
Apollo 24|7 to raise ₹2,475 crores from Advent; merges Keimed into digital arm
Apollo 24/7 is valued at an enterprise value of Rs 14,478 crores. Keimed is valued at an enterprise value of Rs 8,003 crores. Following merger, Keimed shareholders would hold a maximum of 25.7% stake in the combined entity, while AHEL would continue to remain the largest controlling shareholder with at least 59.2% stake.
PE Advent International queues up for a stake in Apollo 24/7
Apollo 24/7 is part of Apollo HealthCo, a subsidiary of Apollo Hospitals. HealthCo also houses the pharmacy distribution business and a 25.5% interest in Apollo Pharmacy. It accounts for about 40% of Apollo Hospitals’ revenue.
Investing in Healthcare Index Funds or ETFs for Future Financial Security
"A number of factors confluence to make India a pharmaceutical powerhouse, some of them being the regulatory framework, lower production costs, and the skilled pool of manpower comprising scientists, researchers, engineers and professionals," said Chintan Haria.
This small cap mutual fund gave 34% returns in three years; should you invest?
Nippon India Small Cap Fund: This small-cap fund’s asset base continues to grow, which has led to its portfolio size ballooning to nearly 200 stocks. Despite its bulky portfolio, the fund has put in an impressive show in recent years, consistently outperforming the index and peers, while boasting superior risk metrics.
India is the 'cancer capital' of the world: Apollo Hospitals' report
India sees a rise in NCDs, notably cancer cases. Apollo Hospitals' report emphasizes urgent interventions for diabetes, hypertension, obesity, and highlights the importance of preventive healthcare measures and early screenings to combat health challenges.
Apollo Hospitals report finds Indians are getting cancer at lower ages than West
The study, which is the fourth edition of its flagship Health of Nation Report, highlighted the fastest rise in cancer cases and also the average age of incidence has also gotten significantly younger in India.
Load More
